Amenorrhea natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
If left untreated, | If left untreated, patients with amenorrhea may progress to develop [[infertility]] and [[osteoporosis]]. Common complications of amenorrhea are based on underlying disorder that induce amenorrhea. [[Prognosis]] is generally excellent and the [[mortality rate]] of patients with amenorrhea is approximately less than 1%, generally in [[brain]] lesions. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
| Line 16: | Line 16: | ||
**[[Menstrual cycle]] is interrupted for at least 3 months, however [[Menstrual cycle|menstrual cycles]] were regular before.<ref name="ChiavaroliDAdamo2011" /> | **[[Menstrual cycle]] is interrupted for at least 3 months, however [[Menstrual cycle|menstrual cycles]] were regular before.<ref name="ChiavaroliDAdamo2011" /> | ||
**[[Menstrual cycle]] is interrupted for at least 6 months, however [[Menstrual cycle|menstrual cycles]] were irregular before.<ref>{{cite book | last = Fritz | first = Marc | title = Clinical gynecologic endocrinology and infertility | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2011 | isbn = 978-0781779685 }}</ref> | **[[Menstrual cycle]] is interrupted for at least 6 months, however [[Menstrual cycle|menstrual cycles]] were irregular before.<ref>{{cite book | last = Fritz | first = Marc | title = Clinical gynecologic endocrinology and infertility | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2011 | isbn = 978-0781779685 }}</ref> | ||
*If left untreated, all | *If left untreated, all patients with amenorrhea may progress to develop [[infertility]] and [[osteoporosis]]. | ||
*The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]]. | *The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]]. | ||
*In | *In case of amenorrhea secondary to [[Asherman syndrome|Asherman's syndrome]], patients usually have a past medical history of [[uterine]] surgery and [[scarring]]. | ||
*[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref> | *[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref> | ||
*In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, | *In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of [[weight loss]] (severe), excessive [[exercise]], or drastic [[emotional stress]] prior to cessation of [[menstruation]].<ref name="pmid25201001">Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25201001 Functional hypothalamic amenorrhea and its influence on women's health.] ''J Endocrinol Invest'' 37 (11):1049-56. [http://dx.doi.org/10.1007/s40618-014-0169-3 DOI:10.1007/s40618-014-0169-3] PMID: [https://pubmed.gov/25201001 25201001]</ref> | ||
*[[Premature ovarian failure]] | *[[Premature ovarian failure]] presents with seen with menopause and elevated levels of [[gonadotropins]]. In age group of 41 to 44 years, it is called pre-[[menopause]]. It is generally related to family history of [[ovarian failure]] in relative females.<ref name="pmid10773392">{{cite journal |vauthors=Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti MG, Dalprà L, Crosignani PG |title=Premature ovarian failure |journal=Mol. Cell. Endocrinol. |volume=161 |issue=1-2 |pages=53–7 |year=2000 |pmid=10773392 |doi= |url=}}</ref> | ||
*Amenorrhea due to [[hyperprolactinemia]], caused by [[prolactin]] overproduction or [[dopamine]] suppression, mostly occurred in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies. There is a little chance of [[pituitary tumor]] in 2-10 years of the [[disease]].<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref> | *Amenorrhea due to [[hyperprolactinemia]], caused by [[prolactin]] overproduction or [[dopamine]] suppression, mostly occurred in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies. There is a little chance of [[pituitary tumor]] in 2-10 years of the [[disease]].<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref> | ||
===Complications=== | ===Complications=== | ||
Revision as of 17:53, 19 October 2017
|
Amenorrhea Microchapters |
|
Patient Information |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Amenorrhea natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Amenorrhea natural history, complications and prognosis |
|
FDA on Amenorrhea natural history, complications and prognosis |
|
CDC on Amenorrhea natural history, complications and prognosis |
|
Amenorrhea natural history, complications and prognosis in the news |
|
Blogs on Amenorrhea natural history, complications and prognosis |
|
Risk calculators and risk factors for Amenorrhea natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Overview
If left untreated, patients with amenorrhea may progress to develop infertility and osteoporosis. Common complications of amenorrhea are based on underlying disorder that induce amenorrhea. Prognosis is generally excellent and the mortality rate of patients with amenorrhea is approximately less than 1%, generally in brain lesions.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of puberty usually develop in the second decade of life, 12-13 years of age and usually before 15 years of age. The main symptom of puberty in female gender is menarche.[1]
- In primary amenorrhea:
- In secondary amenorrhea:
- Menstrual cycle is interrupted for at least 3 months, however menstrual cycles were regular before.[1]
- Menstrual cycle is interrupted for at least 6 months, however menstrual cycles were irregular before.[3]
- If left untreated, all patients with amenorrhea may progress to develop infertility and osteoporosis.
- The majority of amenorrhea cases are caused by four conditions, which include polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
- In case of amenorrhea secondary to Asherman's syndrome, patients usually have a past medical history of uterine surgery and scarring.
- Polycystic ovary syndrome (PCOS), if left untreated can lead to heart disease from elevated cholesterol and increased levels of androgens. Long periods of not having menstrual cycles leads to unopposed exposure of endometrium to estrogen, can result in endometrial cancer.[4]
- In functional (hypothalamic) amenorrhea, the patient usually reports normal regular cycles in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of weight loss (severe), excessive exercise, or drastic emotional stress prior to cessation of menstruation.[5]
- Premature ovarian failure presents with seen with menopause and elevated levels of gonadotropins. In age group of 41 to 44 years, it is called pre-menopause. It is generally related to family history of ovarian failure in relative females.[6]
- Amenorrhea due to hyperprolactinemia, caused by prolactin overproduction or dopamine suppression, mostly occurred in middle aged women. Idiopathic hyperprolactinemia is elevated serum prolactin level without any brain lesion or other pathologies. There is a little chance of pituitary tumor in 2-10 years of the disease.[7]
Complications
- Common complications of amenorrhea are based on the background disease that induced it.
- Common complications of PCOS include:
- Hyperprolactinemia leads to galactorrhea, decreasing libido, and pregnancy complications. In case of prolactin-producing pituitary adenoma, massive enlargement of the tumor may influence the vision and pituitary function. It can also cause osteopenia and osteoporosis in pre-menopausal women.[8]
- Common complications of premature ovarian failure are including infertility, osteoporosis, depression/anxiety, cardiac disease, and dementia.[9]
- Patients with hypothalamic (functional) amenorrhea experience various complications, such as infertility, decrease in bone mineral density (BMD), increased risk for fracture along with cardiovascular and psychological problems.[5]
- The most important complication of premature ovarian failure is infertility, that is preventable to some extend with appropriate therapies. Bone loss and mental problems are other complications.[10]
Prognosis
- Prognosis is generally excellent and the mortality rate of patients with amenorrhea is approximately less than 1%.
- Among patients with androgen insensitivity syndrome there is an increased risk of testicular cancer, and surveillance should be done at appropriate intervals.
- Prognosis of polycystic ovary syndrome (PCOS) is generally good, long term diet and exercise along with metformin therapy decrease the cardiovascular and pregnancy problems in the future.[11]
- Long term (7 years) prognosis of hyperprolactinemia due to microadenomas showed 90-95% stability or gradual decrease of prolactin serum level. Whereas, one third of patients with idiopathic hyperprolactinemia are cured without therapy, two third if basal prolactin < 40 ng/mL. 40% of macroadenomas relapse during 5 years after surgery.[12]
References
- ↑ 1.0 1.1 Chiavaroli, Valentina; DAdamo, Ebe; Diesse, Laura; de, Tommaso; Chiarelli, Francesco; Moh, Angelika (2011). "Primary and Secondary Amenorrhea". doi:10.5772/17675.
- ↑ Herman-Giddens, M. E.; Slora, E. J.; Wasserman, R. C.; Bourdony, C. J.; Bhapkar, M. V.; Koch, G. G.; Hasemeier, C. M. (1997). "Secondary Sexual Characteristics and Menses in Young Girls Seen in Office Practice: A Study from the Pediatric Research in Office Settings Network". PEDIATRICS. 99 (4): 505–512. doi:10.1542/peds.99.4.505. ISSN 0031-4005.
- ↑ Fritz, Marc (2011). Clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-0781779685.
- ↑ Palomba S, Santagni S, Falbo A, La Sala GB (2015). "Complications and challenges associated with polycystic ovary syndrome: current perspectives". Int J Womens Health. 7: 745–63. doi:10.2147/IJWH.S70314. PMC 4527566. PMID 26261426.
- ↑ 5.0 5.1 Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) Functional hypothalamic amenorrhea and its influence on women's health. J Endocrinol Invest 37 (11):1049-56. DOI:10.1007/s40618-014-0169-3 PMID: 25201001
- ↑ Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti MG, Dalprà L, Crosignani PG (2000). "Premature ovarian failure". Mol. Cell. Endocrinol. 161 (1–2): 53–7. PMID 10773392.
- ↑ Mattei AM, Severini V, Crosignani PG (1991). "Natural history of hyperprolactinemia". Ann. N. Y. Acad. Sci. 626: 130–6. PMID 2058949.
- ↑ Sanfilippo JS (1999). "Implications of not treating hyperprolactinemia". J Reprod Med. 44 (12 Suppl): 1111–5. PMID 10649820.
- ↑ "Premature ovarian failure - Symptoms and causes - Mayo Clinic".
- ↑ Nelson LM (2009). "Clinical practice. Primary ovarian insufficiency". N Engl J Med. 360 (6): 606–14. doi:10.1056/NEJMcp0808697. PMC 2762081. PMID 19196677.
- ↑ Hart R (2007). "Polycystic ovarian syndrome--prognosis and treatment outcomes". Curr. Opin. Obstet. Gynecol. 19 (6): 529–35. doi:10.1097/GCO.0b013e3282f10e22. PMID 18007129.
- ↑ "Hyperprolactinemia Follow-up: Further Outpatient Care, Complications, Prognosis".